Bahl & Gaynor Inc Abb Vie Inc. Transaction History

Bahl & Gaynor Inc

$17.9 Billion
Q1 2024

A detailed history of Bahl & Gaynor Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Bahl & Gaynor Inc holds 3,294,272 shares of ABBV stock, worth $551 Million. This represents 3.34% of its overall portfolio holdings.

Number of Shares

3,294,272

Previous 3,343,889 1.48%

Holding current value

$551 Million

Previous $518 Million 15.76%

% of portfolio

3.34%

Previous 3.12%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$159.82 - $182.1 $7.93 Million - $9.04 Million	-49,617 Reduced 1.48%	3,294,272 $600 Million
Q4 2023 Feb 02, 2024	SELL	$137.6 - $154.97 $15.3 Million - $17.2 Million	-111,042 Reduced 3.21%	3,343,889 $518 Million
Q3 2023 Nov 03, 2023	SELL	$133.59 - $154.65 $4.59 Million - $5.31 Million	-34,330 Reduced 0.98%	3,454,931 $515 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $73.1 Million - $91 Million	-551,766 Reduced 13.65%	3,489,261 $470 Million
Q1 2023 May 03, 2023	BUY	$144.61 - $166.54 $104 Million - $120 Million	719,343 Added 21.66%	4,041,027 $644 Million

Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $24.7 Million - $29.6 Million	-178,732 Reduced 5.11%	3,321,684 $537 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $24.3 Million - $27.9 Million	181,182 Added 5.46%	3,500,416 $470 Million
Q2 2022 Aug 08, 2022	BUY	$137.62 - $174.96 $98.1 Million - $125 Million	712,973 Added 27.36%	3,319,234 $508 Million
Q1 2022 May 12, 2022	SELL	$131.98 - $163.75 $92.2 Million - $114 Million	-698,351 Reduced 21.13%	2,606,261 $423 Million
Q4 2021 Feb 10, 2022	SELL	$107.43 - $135.93 $7.5 Million - $9.49 Million	-69,793 Reduced 2.07%	3,304,612 $447 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $2.21 Million - $2.51 Million	20,783 Added 0.62%	3,374,405 $364 Million
Q2 2021 Aug 06, 2021	SELL	$105.21 - $117.21 $612,006 - $681,810	-5,817 Reduced 0.17%	3,353,622 $378 Million
Q1 2021 May 11, 2021	BUY	$102.3 - $112.62 $9.41 Million - $10.4 Million	91,964 Added 2.81%	3,359,439 $364 Million
Q4 2020 Feb 02, 2021	BUY	$80.49 - $108.67 $15.2 Million - $20.5 Million	188,896 Added 6.14%	3,267,475 $350 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $39.3 Million - $46.1 Million	457,500 Added 17.45%	3,078,579 $270 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $49.8 Million - $66.6 Million	678,689 Added 34.94%	2,621,079 $257 Million
Q1 2020 May 26, 2020	BUY	$64.5 - $97.79 $92.4 Million - $140 Million	1,433,191 Added 281.46%	1,942,390 $148 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $12.1 Million - $18.4 Million	-188,206 Reduced 26.99%	509,199 $38.8 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $7.15 Million - $8.95 Million	-99,187 Reduced 12.45%	697,405 $61.7 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $37 Million - $44.4 Million	-586,965 Reduced 42.42%	796,592 $60.3 Million
Q2 2019 Aug 12, 2019	BUY	$65.7 - $83.98 $22.3 Million - $28.5 Million	338,941 Added 32.45%	1,383,557 $101 Million
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $93.6 Million - $110 Million	-1,213,555 Reduced 53.74%	1,044,616 $84.2 Million
Q4 2018 Feb 12, 2019	BUY	$77.85 - $96.01 $31.7 Million - $39.1 Million	407,539 Added 22.02%	2,258,171 $208 Million
Q3 2018 Nov 09, 2018	SELL	$88.91 - $98.84 $62.8 Million - $69.8 Million	-706,683 Reduced 27.63%	1,850,632 $175 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $215 Million - $255 Million	-2,399,597 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$92.01 - $123.21 $13.8 Million - $18.5 Million	-149,860 Reduced 5.88%	2,399,597 $227 Million
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $38.7 Million - $42.5 Million	432,399 Added 20.42%	2,549,457 $247 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $17.2 Million - $22 Million	246,861 Added 13.2%	2,117,058 $188 Million
Q2 2017 Aug 11, 2017	SELL	N/A	-17,254 Reduced 0.91%	1,870,197 $136 Million
Q2 2017 Aug 10, 2017	BUY	N/A	1,887,451	1,887,451 $118 Million

Others Institutions Holding ABBV

# of Institutions

3,653

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $296B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bahl & Gaynor Inc with notifications on news.

Account